J B Chemicals and Pharmaceuticals Intrinsic Value
JBCHEPHARM • Healthcare
Current Stock Price
₹1961.90
Primary Intrinsic Value
₹1169.52
Market Cap
₹3139 Cr
+100.0%
Upside
Median Value
₹3923.80
Value Range
₹589 - ₹4905
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
JBCHEPHARM Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1169.52 | ₹935.62 - ₹1403.42 | -40.4% | EPS: ₹53.16, Sector P/E: 22x |
| Book Value Method | asset | ₹4291.25 | ₹3862.12 - ₹4720.38 | +118.7% | Book Value/Share: ₹2145.62, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹3923.80 | ₹3531.42 - ₹4316.18 | +100.0% | Revenue/Share: ₹2750.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹3923.80 | ₹3531.42 - ₹4316.18 | +100.0% | EBITDA: ₹1300.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹4904.75 | ₹3923.80 - ₹5885.70 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹588.57 | ₹529.71 - ₹647.43 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹821.32 | ₹739.19 - ₹903.45 | -58.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹3923.80 | ₹3531.42 - ₹4316.18 | +100.0% | ROE: 24.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1601.99 | ₹1441.79 - ₹1762.19 | -18.3% | EPS: ₹53.16, BVPS: ₹2145.62 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
JBCHEPHARM Intrinsic Value Analysis
What is the intrinsic value of JBCHEPHARM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of J B Chemicals and Pharmaceuticals (JBCHEPHARM) is ₹3923.80 (median value). With the current market price of ₹1961.90, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹588.57 to ₹4904.75, indicating ₹588.57 - ₹4904.75.
Is JBCHEPHARM undervalued or overvalued?
Based on our multi-method analysis, J B Chemicals and Pharmaceuticals (JBCHEPHARM) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 24.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.03x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for J B Chemicals and Pharmaceuticals
Additional stock information and data for JBCHEPHARM
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹903 Cr | ₹755 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹801 Cr | ₹599 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹626 Cr | ₹145 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹170 Cr | ₹170 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹315 Cr | ₹200 Cr | Positive Free Cash Flow | 8/10 |